<DOC>
	<DOC>NCT01518920</DOC>
	<brief_summary>The objective of this study is to examine the safety, tolerability, and effects on hearing thresholds of two single doses of PF-04958242 and placebo in subjects with age-related hearing loss.</brief_summary>
	<brief_title>A Study Of The Effects Of PF-04958242 In Subjects With Age-Related Hearing Loss</brief_title>
	<detailed_description />
	<mesh_term>Hearing Loss</mesh_term>
	<mesh_term>Deafness</mesh_term>
	<mesh_term>Hearing Loss, Sensorineural</mesh_term>
	<criteria>Subjects must have a current diagnosis of age related sensorineural hearing loss in the range of 3060 dB, averaged over 2 and 4 kHz in at least one ear. Subjects must have symmetric hearing loss Subjects who can read, speak and comprehend English. Subjects who have a history of sudden hearing loss and history or diagnosis of rapidly progressive idiopathic hearing loss Subjects who have hearing disorders other than age related sensorineural hearing loss Subjects with moderate or greater tinnitus Pregnant females; breastfeeding females; females of childbearing potential</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>Age related sensorineural hearing loss</keyword>
	<keyword>PF-04958242</keyword>
</DOC>